Valeriana officinalis ameliorates vacuous chewing movements induced by reserpine in rats

Journal of Neural Transmission

Volumn 118, Issue 11, 2011, Pages 1547-1557

  Pereira, Romaiana Picada ^a,c   Fachinetto, Roselei ^a,c   De Souza Prestes, Alessandro ^a   Wagner, Caroline ^a   Sudati, Jéssie Haigert ^a   Boligon, Aline Augusti ^a   Athayde, Margareth Linde ^a   Morsch, Vera Maria ^a   Rocha, João Batista Teixeira ^b,c  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

^b ABDUS SALAM INTERNATIONAL CENTRE FOR THEORETICAL PHYSICS   (Italy)

^c Laboratorio de Sintese   (Brazil)

Author keywords

Oral dyskinesia; Parkinson's disease; Reserpine; Vacuous chewing movements; Valeriana officinalis

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ANTIOXIDANT; DRINKING WATER; GALLIC ACID; REACTIVE OXYGEN METABOLITE; RESERPINE; VALERIAN; VALERIC ACID;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN CORTEX; CELL VIABILITY; CLINICAL ASSESSMENT; CONTROLLED STUDY; DRUG EFFECT; GABAERGIC TRANSMISSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIPPOCAMPUS; IN VITRO STUDY; LOCOMOTION; MALE; MASTICATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OPEN FIELD TEST; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA; VACUOUS CHEWING MOVEMENT; VALERIANA OFFICINALIS;

EID: 84983718351     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-011-0640-7     Document Type: Article

References (78)

1. Abílio VC, Vera JAR Jr, Ferreira LSM, Duarte CRM, Carvalho RC, rassl C, Martins CR, Torres-Leite D, Bignotto M, Tufik S, Ribeiro R de A, Frussa-Filho R (2002) Effects of melatonin on orofacial movements in rats. Psychopharmacology 161:340-347 (Pubitemid 34595784)
2. Abílio VC, Araujo CCS, Bergamo M, Calvente PRV, D'Almeida V, ibeiro R de A, Frussa-Filho R (2003) Vitamin E attenuates reserpine induced oral dyskinesia and striatal GSSG/GSH ratio enhancement in rats. Prog Neuropsychopharmacol Biol Psychiatry 27:109-114 (Pubitemid 36126651)
3. Abílio VC, Silva RH, Carvalho RC, Grassl C, Calzavara MB, Registro S, D'Almeida V, Ribeiro R de A, Frussa-Filho R (2004) Important role of striatal catalase in aging- and reserpineinduced oral dyskinesia. Neuropharmacology 47:263-272 (Pubitemid 38824650)
4. Abourashed EA, Koetter U, Brattstrom A (2004) In vitro binding experiments with a Valerian, hops and their fixed combination extract (Ze91019) to selected central nervous system receptors. Phytomedicine 11:633-638 (Pubitemid 40007746)
5. Aguiar AS Jr, Araújo AL, da-Cunha TR, Speck AE, Ignácio ZM, De-Mello N, Prediger RDS (2009) Physical exercise improves motor and short-term social memory déficits in reserpinized rats. Brain Res Bull 79:452-457
6. Aisen P, Wessling-Resnick M, Leibold EA (1999) Iron metabolism. Curr Opin Chem Biol 3:200-206 (Pubitemid 29145787)
7. Andreassen OA, Jorgensen HA (2000) Neurotoxicity associated with neuroleptic induced oral dyskinesias in rats. Implications for tardive dyskinesia? Prog Neurobiol 61:525-541 (Pubitemid 30169057)
8. Araujo NP, Abílio VC, Silva RH, Pereira RC, Carvalho RC, Gonzalez C, Bellot RG, Castro JPMV, Fukushiro DF, Rodrigues MSD, hinen CC, Frussa-Filho R (2005) Effects of topiramate on oral dyskinesia induced by reserpine. Brain Res Bull 64:331-337
9. Arreguin S, Nelson P, Padway S, Shirazi M, Pierpont C (2009) Dopamine complexes of iron in the etiology and pathogenesis of Parkinson's disease. J Inorg Biochem 103:87-93
10. Ban JY, Nguyen TTH, Lee HJ, Cho SO, Ju HS, Kim JY, Bae KH, Song KS, Seong YH (2008) Neuroprotective properties of gallic acid from Sanguisorbae radix on amyloid b protein (25-35) induced toxicity in cultured rat cortical. Neurons Biol Pharm ull 31:149-153
11. Baskin P, Salamone J (1993) Vacuous jaw movements in rats induced by acute reserpine administration: interactions with different doses of apomorphine. Pharmacol Biochem Behav 46:793-797
12. Bilska A, Dubiel M (2007) Alpha-lipoic acid differently affects the reserpine-induced oxidative stress in the striatum and prefrontal cortex of rat brain. Neuroscience 146:1758-1771 (Pubitemid 46783235)
13. Bove J, Prou D, Perier C, Przedborski S (2005) Toxin-induced models of Parkinson's disease. NeuroRx 2:484-494 (Pubitemid 41444882)
14. Broadhurst PL (1960) Experiments in psychogenetics. In: Eysenk HJ (ed). Experiments in personality. Routledge & Kegan Paul, London, p 76
15. Burger ME, Audrei A, Callegari L, Athayde FR, Nogueira CW, Zeni G, Rocha JBT (2003) Ebselen attenuates reserpine-induced orofacial dyskinesia and oxidative stress in rat striatum. Prog Neuropsychopharmacol Biol Psychiatry 27:135-140 (Pubitemid 36126655)
16. Burger ME, Fachinetto R, Calegari L, Paixão MW, Braga AL, Rocha JBT (2004) Effects on age on orofacial dyskinesia reserpineinduced and possible protection of diphenyl-diselenide. Brain es Bull 64:339-345 (Pubitemid 39550770)
17. Burger ME, Fachineto R, Alves A, Callegari L, Rocha JBT (2005a) Acute reserpine and subchronic haloperidol treatments change synaptosomal brain glutamate uptake and elicit orofacial dyskinesia in rats. Brain Res 1031:202-210 (Pubitemid 40103531)
18. Burger ME, Fachineto R, Zeni G, Rocha JBT (2005b) Ebselen attenuates haloperidol induced orofacial dyskinesia and oxidative stress in rat brain. Pharmacol Biochem Behav 81:608-615 (Pubitemid 40966809)
19. Busanello A, Peroza LR, Farias LE, Burger ME, Barreto KP, Barbosa NBV, Fachinetto R (2011) Resveratrol protects against a model of vacuous chewing movements induced by reserpine in mice. Behav Pharmacol 22:71-75
20. Carvalho RC, Silva RH, Abílio VC, Barbosa PN, Frussa-Filho R (2003) Antydiskinetic effects of risperidone on animal models of tardive dyskinesia in mice. Brain Res Bull 60:115-124 (Pubitemid 36511393)
21. Castro JPMV, Frussa-Filho R, Fukushiro DF, Silva RH, Medrano A, Ribeiro R de A, Abílio VC (2006) Effects of baclofen on reserpine-induced vacuous chewing movements in mice. Brain Res Bull 68:436-441 (Pubitemid 43177579)
22. Cavadas C, Araujo I, Cotrim MD, Amaral T, Cunha AP, Macedo T, Ribeiro CF (1995) In vitro study on the interaction of Valeriana officinalis L. extracts and their amino acids on GABAA receptor in rat brain. Arzneimittelforschung 45:753-755
23. Dekeyser J (1991) Excitotoxic mechanisms may be involved in the pathophysiology of tardive-dyskinesia. Clin Neuropharmacol 14:562-565
24. DonaireAM, Gil-SaladieD(2001) Progressive primary aphasia associated with corticobasal degeneration. Rev Neurol 32:1051-1054
25. Egan ME, Apud J, Wyatt RJ (1997) Treatment of tardive dyskinesia. Schizophr Bul 23:583-609 (Pubitemid 27485969)
26. Fachinetto R, Villarinho JG, Wagner C, Pereira RP, Puntel RL, Paixão MW, Braga AL, Calixto JB, Rocha JBT, Ferreira J (2007a) Diphenyl diselenide decreases the prevalence of vacuous chewing movements induced by fluphenazine in rats. Psychopharmacology 194:423-432 (Pubitemid 47389341)
27. Fachinetto R, Villarinho JG, Wagner C, Pereira RP, Ávila DS, Burger E, Calixto JB, Rocha JBT, Ferreira J (2007b) Valeriana officinalis does not alter the orofacial dyskinesia induced by haloperidol in rats: role of dopamine transporter. Prog Neuropsychopharmacol Biol Psychiatry 31:1478-1486 (Pubitemid 47302567)
28. Faria RR, Abílio VC, Grassl C, Chinen CC, Ribeiro LT, Castro JPMV, Fukushiro DF, Dutra-Rodrigues MS, Zanier-Gomes PH, egistro S, Carvalho RC, D'Almeida V, Silva RH, Ribeiro R de A, Frussa-Filho R (2005) Beneficial effects of vitamin C and vitamin E on reserpine induced oral dyskinesia in rats: critical role of striatal catalase activity. Neuropharmacology 48:993-1001 (Pubitemid 40602607)
29. Fibiger HC, Lloyd KG (1984) Neurobiological substrates of tardivedyskinesia-the GABA hypothesis. Trends Neurosci 7:462-464 (Pubitemid 15156977)
30. Fiske CF, Subbarow Y (1925) The colorimetric determination of hosphorus. J Biol Chem 66:375-400
31. Fugh-Berman A, Cott JM (1999) Dietary supplements and natural roducts as psychotherapeutic agents. Psychosom Med 61:712-728 (Pubitemid 29455091)
32. Gao XM, Kakigi T, Friedman MB, Tamminga CA (1994) Tiagabine nhibits haloperidol-induced oral dyskinesias in rats. J Neural Transm Gen Sect 95:63-69
33. Houghton PJ (1999) The scientific basis for the reputed activity of alerian. J Pharm Pharmacol 51:505-512 (Pubitemid 29319774)
34. Jicha GA, Salomone JD (1991) Vacuous jaw movements and feeding deficits in rats with ventrolateral striatal dopamine depletion: possible relation to parkinsonian symptoms. J Neurosci 11:3822-3829
35. Kaneda H, Shirakawa O, Dale J, Goodman L, Bachus SE, Tamminga A (1992) Co-administration of progabide inhibits haloperidolinduced oral dyskinesias in rats. Eur J Pharmacol 121:43-49
36. Kulkarni SK, Dhir A (2008) Withania somnifera: an Indian ginseng. Prog Neuropsychopharmacol Biol Psychiatry 32:1093-1105
37. Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz AG et al (1990) Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 86:464-478 (Pubitemid 20279989)
38. Llorca PM, Chereau I, Bayle FJ, Lancon C (2002) Tardive dyskinesia and antipsychotics: a review. Eur Psychiatry 17:129-138
39. Lohr JB, Kuczenski R, Niculescu AB (2003) Oxidative mechanisms and tardive dyskinesia. CNS Drugs 17:47-62 (Pubitemid 36044348)
40. Malva JO, Santos S, Macedo T (2004) Neuroprotective properties of Valeriana officinalis extracts. Neurotox Res 6:131-140
41. McCabe S (2002) Complimentary herbal and alternative drugs in clinical practice. Perspect Psychiatr Care 38:98-107
42. Mennini T, Bernasconi P, Bombardelli E, Morazzoni P (1993) In vitro study on the interaction of extracts and pure compounds from Valeriana officinalis roots with GABA, benzodiazepine and arbiturate receptors in rat brain. Fitoterapia 64:291-300 (Pubitemid 23303637)
43. Morazzoni P, Bombardelli E (1995) Valeriana offcinalis: traditional use and recent evaluation of activity. Fitoterapia 66:99-112
44. Morselli PL, Fournier V, Bossi L, Musch B (1985) Clinical activity of GABA agonists in neuroleptic- and L-dopa-induced dyskinesia. Psychopharmacology 2:128-136
45. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay. Immunol Methods 16:55-63 (Pubitemid 14203433)
46. Naidu PS, Singh A, Kulkarni SK (2004) Reversal of reserpineinduced orofacial dyskinesia and cognitive dysfunction by quercetin. Pharmacology 70:59-67 (Pubitemid 38032498)
47. Naidu PS, Singh A, Kulkarni SK (2006) Effect of Withania somnifera root extract on reserpine-induced orofacial dyskinesia and ognitive dysfunction. Phytother Res 20:140-146 (Pubitemid 43266840)
48. Neisewander JL, Lucki I, Mcgonigle P (1991) Neurochemical changes associated with the persistence of spontaneous oral dyskinesia in rats following chronic reserpine treatment. Brain Res 558:27-35
49. Neisewander JL, Castañeda E, Davis DA (1994) Dose-dependent differences in the development of reserpine-induced oral dyskinesia in rats: support for a model of tardive dyskinesia. Psychopharmacology 116:79-84 (Pubitemid 24279600)
50. Ohkawa H, Ohishi H, Yagi K (1979) Assay for lipid peroxide in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351-358 (Pubitemid 9194347)
51. Oliveira DM, Barreto G, De Andrade DEV, Saraceno E, Aon- Bertolino L, Capani F, El Bacha RS, Giraldez LD (2009) ytoprotective effect of Valeriana officinalis extract on an in vitro experimental model of Parkinson disease. Neurochem Res 34:215-220
52. Ortiz JG, Nieves-Natal J, Chavez P (1999) Effects of Valeriana officinalis extracts on [3H]flunitrazepam binding, synaptosomal [3H]GABA uptake, and hippocampal [3H]GABA release. NeurochemRes 24:1373-1378
53. Paille V, Brachet P, Damier P (2004a) Role of nigral lesion in the genesis of dyskinesias in a rat model of Parkinson's disease. Neuroreport 15:561-564 (Pubitemid 38328160)
54. Paille V, Brachet P, Damier P (2004b) Role of nigral lesion in the genesis of dyskinesias in a rat model of Parkinson's disease. Neuroreport 15:561-564 (Pubitemid 38328160)
55. Peixoto MF, Abílio VC, Silva RH, Frussa-Filho R (2003) Effects of valproic acid on an animal model of tardive dyskinesia. Behav Brain Res 142:229-233 (Pubitemid 36681560)
56. Peixoto MF, Araujo NP, Silva RH, Castro JPMV, Fukushiro DF, Faria RR, Zanier-Gomes PH, Medrano WA, Frussa-Filho R, Abílio VC (2005) Effects of gabaergic drugs on reserpineinduced oral dyskinesia. Behav Brain Res 160:51-59
57. Pereira RP, Fachinetto R, Prestes AS, Puntel RL, Silva GNS, Heinzmann BM, Boschetti TK, Athayde ML, Burger ME, Morel AF, Morsh VM, Rocha JBT (2009) Antioxidant effects of different extracts from Melissa officinalis, Matricaria recutita and Cymbopogon citrates. Neurochem Res 34:973-983
58. Pérez-Severiano P, Rodríguez-Pérez M, Pedraza-Chaverrí J, Maldonado PD, Medina-Campos ON, Ortíz-Plata A, Sánchez-García A, Villeda-Hernández J, Galván-Arzate S, Aguilera P, Santamar?́04) S-Allylcysteine, a garlic-derived antioxidant, meliorates quinolinic acid-induced neurotoxicity and oxidative damage in rats. Neurochem Int 45:1175-1183
59. Qian ZM, Wang Q, Pu Y (1997) Brain iron and neurological disorders. Chin Med J 110:455-458
60. Raghavendra V, Naidu PS, Kulkarni SK (2001) Reversal of reserpine induced vacuous chewing movements in rats by melatonin: involvement of peripheral benzodiazepine receptors. Brain Res 904:149-152 (Pubitemid 32545365)
61. Salamone JD, Baskin P (1996) Vacuous jaw movements induced by acute reserpine and low-dose apomorphine: possible mode of parkinsonian tremor. Pharmacol Biochem Behav 53:179-83 (Pubitemid 26117741)
62. Santos MS, Ferreira F, Cunha AP, Carvalho AP, Macedo T (1994) An aqueous extract of valerian influences the transport of GABA in synaptosomes. Planta Med 60:278-279 (Pubitemid 24207726)
63. Smythies J (1999) The neurotoxicity of glutamate, dopamine, iron nd reactive oxygen species: functional interrelationship in health and disease. Neurotoxicol Res 1:27-39
64. Sudati JH, Fachinetto R, Pereira RP, Boligon AA, Athayde ML, Soares FA, Barbosa NBV, Rocha JBT (2009) In vitro antioxidant activity of Valeriana officinalis against different neurotoxic gents. Neurochem Res 34:1372-1379
65. Swaiman KF (1991) Hallervorden-Spatz and brain iron metabolism. Arch Neurol 48:1285-1293
66. Tabach R, Rodrigues E, Carlini EA (2009) Preclinical toxicological assessment of a phytotherapeutic product-CPV (based on dry extracts of Crataegus oxyacantha L., Passiflora incarnata L., and Valeriana officinalis L.). Phytotherapy Res 23:33-40
67. Tamminga CA, Crayton JW, Chase TN (1979) Improvement in tardive dyskinesia after muscimol therapy. Arch Gen Psychiatry 36:595-598 (Pubitemid 9201192)
68. Tamminga CA, Thaker GK, Ferraro TN, Hare TA (1983) GABA agonist treatment improves tardive-dyskinesia. Lancet 2:97-98 (Pubitemid 13066573)
69. Teixeira AM, Reckziegel P, Muller L, Pereira RP, Roos D, Rocha JBT, Burger ME (2009) Intense exercise potentiates oxidative stress in striatum of reserpine-treated animals. Pharmacol Biochem Behav 92:231-235
70. Thaakur Himabindhu (2009) Effect of alpha lipoic acid on the tardive dyskinesia and oxidative stress induced by haloperidol in rats. J Neural Transm 116:807-814
71. Thevenod F, Friedmann JM (1999) Cadmium-mediated oxidative stress in kidney proximal tubule cells induces degradation of Na?/K?-ATPase through proteasomal and endo-/lysosomal proteolytic pathways. FASEB J 13:1751-1761 (Pubitemid 29473337)
72. Thomas B, Beal MF (2007) Parkinson's disease. Human Mol Genet 16:R183-R194
73. Von der Hude W, Scheutwinkel-Reich M, Braun R, Dittmar W et al (1985) In vitro mutagenicity of valepotriates. Arch Toxicol 56:267-271 (Pubitemid 15104922)
74. Waddington JL (1990) Spontaneous orofacial movements induced in rodents by very long-term neuroleptic drug administration: phenomenology, pathophysiology and putative relationship to tardive dyskinesia. Psychopharmacology 101:431-447 (Pubitemid 20220034)
75. White HS, Brown SD, Skeen GA, Wolf HH, Twyman RE (1997a) The anticonvulsant topiramate displays a unique ability to otentiate GABA-evoked chloride current. Epilepsia 36:S39-S40
76. White HS, Brown SD, Woodhead JH, Skeen GA, Wolf HH (1997b) Topiramate enhances GABA-mediated chloride flux and GABAevoked hloride currents in murine brain neurons and increases eizure threshold. Epilepsy Res 28:167-179 (Pubitemid 27400459)
77. Wu JW, Hsieh CL, Wang HY, Chen HY (2009) Inhibitory effects of guava (Psidium guajava L.) leaf extracts and its active compounds on the glycation process of protein. Food Chem 113:78-84
78. Yan LJ, Traber MG, Packer L (1995) Spectrophotometric method for determination of carbonyls in oxidatively modified apolipoprotein B of human low-density lipoproteins. Anal Biochem 228:349-351